Structure, assembly, and function of tripartite efflux and type 1 secretion systems in gram-negative bacteria

I Alav, J Kobylka, MS Kuth, KM Pos, M Picard… - Chemical …, 2021 - ACS Publications
Tripartite efflux pumps and the related type 1 secretion systems (T1SSs) in Gram-negative
organisms are diverse in function, energization, and structural organization. They form …

Role of bacterial efflux pumps in biofilm formation

I Alav, JM Sutton, KM Rahman - Journal of Antimicrobial …, 2018 - academic.oup.com
Efflux pumps are widely implicated in antibiotic resistance because they can extrude the
majority of clinically relevant antibiotics from within cells to the extracellular environment …

Structure of the AcrAB–TolC multidrug efflux pump

D Du, Z Wang, NR James, JE Voss, E Klimont… - Nature, 2014 - nature.com
The capacity of numerous bacterial species to tolerate antibiotics and other toxic compounds
arises in part from the activity of energy-dependent transporters. In Gram-negative bacteria …

Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria

M Arzanlou, WC Chai, H Venter - Essays in biochemistry, 2017 - portlandpress.com
Gram-negative bacteria are responsible for a large proportion of antimicrobial-resistant
infections in humans and animals. Among this class of bacteria are also some of the most …

[HTML][HTML] Inhibiting bacterial drug efflux pumps via phyto-therapeutics to combat threatening antimicrobial resistance

V Shriram, T Khare, R Bhagwat, R Shukla… - Frontiers in …, 2018 - frontiersin.org
Antibiotics, once considered the lifeline for treating bacterial infections, are under threat due
to the emergence of threatening antimicrobial resistance (AMR). These drug-resistant …

[HTML][HTML] RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition

H Venter, R Mowla, T Ohene-Agyei, S Ma - Frontiers in microbiology, 2015 - frontiersin.org
Drug efflux protein complexes confer multidrug resistance on bacteria by transporting a wide
spectrum of structurally diverse antibiotics. Moreover, organisms can only acquire resistance …

Efflux pump inhibitors of clinically relevant multidrug resistant bacteria

A Lamut, L Peterlin Mašič, D Kikelj… - Medicinal Research …, 2019 - Wiley Online Library
Bacterial infections are an increasingly serious issue worldwide. The inability of existing
therapies to treat multidrug‐resistant pathogens has been recognized as an important …

[HTML][HTML] Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa

J Dreier, P Ruggerone - Frontiers in microbiology, 2015 - frontiersin.org
Pseudomonas aeruginosa infections are becoming increasingly difficult to treat due to
intrinsic antibiotic resistance and the propensity of this pathogen to accumulate diverse …

[HTML][HTML] Antibiotic export by MexB multidrug efflux transporter is allosterically controlled by a MexA-OprM chaperone-like complex

M Glavier, D Puvanendran, D Salvador… - Nature …, 2020 - nature.com
The tripartite multidrug efflux system MexAB-OprM is a major actor in Pseudomonas
aeruginosa antibiotic resistance by exporting a large variety of antimicrobial compounds …

[HTML][HTML] Structures of the wild-type MexAB–OprM tripartite pump reveal its complex formation and drug efflux mechanism

K Tsutsumi, R Yonehara, E Ishizaka-Ikeda… - Nature …, 2019 - nature.com
Abstract In Pseudomonas aeruginosa, MexAB–OprM plays a central role in multidrug
resistance by ejecting various drug compounds, which is one of the causes of serious …